COBAS 4800 HPV TEST, CE-IVD 05235901190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2013-12-24 for COBAS 4800 HPV TEST, CE-IVD 05235901190 manufactured by Roche Molecular Systems.

Event Text Entries

[4118048] A customer from the (b)(6) filed a complaint alleging that discrepant (b)(6) results were generated for one patient specimen in three separate runs when using the cobas 4800 hpv test with three different kit lots (r15771, r16114, s01192). The customer was using the previously tested (b)(6) patient specimen as an external (b)(4) control and some of the targets tested (b)(4) in the three runs. Mdr 2243471-2013-00040 is being filed for the results generated with cobas hpv test lot r15771. Mdr 2243471-2013-00041 is being filed for the results generated with cobas hpv test lot r16114. Mdr 2243471-2013-00042 is being filed for the results generated with cobas hpv test lot s01192.
Patient Sequence No: 1, Text Type: D, B5


[11462342] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of the investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[24935355] The complaint alleged discrepant (b)(6) results were generated for one patient specimen when using the cobas 4800 (b)(6) test. The customer was using the previously tested negative (b)(6) patient specimen as an external negative control and it tested (b)(6) on a subsequent run. The customer selected the sample randomly as an internal negative control as per the cervical screening guidelines in the (b)(6). Although requested, the initial runs for the alleged sample in which the sample tested negative were not available for ct comparison. As the 'internal negative control', used during the customer's runs are selected at random, the customer has admitted that it is possible that the incorrect sample was selected for this subsequent run. The customer uses a manual sample ordering system; they do not give these particular sample a unique identifiers therefore there is no way of checking if the correct sample was used as the 'internal negative control'. It is not recommended to use previously tested patient samples as 'internal negative controls' as result discrepancies may be generated if the sample (s) contain a concentration of virus near the limit of detection of the test; additionally, the cobas 4800 (b)(6) test requires and has been validated to use the test's negative control. Retain testing of the complaint kit met specification. The sample in question is no longer available for investigative testing. There is no indication of a product non-conformance. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2013-00042
MDR Report Key3535288
Report Source01,05
Date Received2013-12-24
Date of Report2014-03-07
Date of Event2013-10-28
Date Mfgr Received2014-03-07
Date Added to Maude2014-04-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS 4800 HPV TEST, CE-IVD
Generic NameKIT, DNA DETECTION, HUMAN PAPILLOMA VIRUS
Product CodeMAQ
Date Received2013-12-24
Catalog Number05235901190
Lot NumberS01192
Device Expiration Date2015-03-31
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2013-12-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.